Healthcare -
Biotechnology - NASDAQ - US
$ 325.45
-1.31 %
$ 14.7 B
Market Cap
12.74
P/E
UTHR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities UTHR - United Therapeutics Corporation
-1.25 B
LAST VALUE
-320.02%
2 YEAR CAGR
-25.01%
5 YEAR CAGR
-8.09%
10 YEAR CAGR